Get contact details including emails and phone numbers Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics's founder is Prashant Mali. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Boston, MA 02111. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. A free inside look at company reviews and salaries posted anonymously by employees. Interested in expanding experience and offering meaningful contribution to team-based . Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. 56% of the management team is White. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Explore {Shape Therapeutics's key management people. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Up to 5 Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Get the full list, Youre viewing 5 of 9 board members. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. ProQR Therapeutics Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Shape Life! SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. . Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. You can find us at shapetx.com and on LinkedIn and Twitter. Win whats next. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. CAR T-cell therapy to overcome. Im thrilled to join such a talented team of innovative thinkers. Shape Life! Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. We [] Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. resistance to cancer treatment. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. A free inside look at company reviews and salaries posted anonymously by employees. Contact We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Shape Therapeutics's is . Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. . Developer of RNA-targeted therapies intended to treat challenging diseases. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Great team culture. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. About. Shape Therapeutics, Inc. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Im thrilled to join such a talented team of innovative thinkers. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Powered by Madgex Job Board Software. It focuses on RNA-editing gene therapy. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. The net loss for the full . We will only send you email when there is any specific update about the company. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Shape Therapeutics, Inc. employs 14 employees. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Its very rewarding. There isnt a path to guide us. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Shape Therapeutics, Inc. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. As Doug noted, our full year net product revenue was $843.8 million . Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. You can read more about your. Learn more. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. John C. Martin, Ph.D., was elected to our Board in January 2020. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. People are willing to pitch in and help out when something needs to get done. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Personalize which data points you want to see and create visualizations instantly. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . cindy@shaptetx.com, 1985 - 2023 BioSpace.com. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Chief Business Officer, Will Krause Search over 700 PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Our Commitment to Diversity. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Last Funding Type Series B. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Life! about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. million verified professionals across 35 million companies. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. All content is posted anonymously by employees working at Shape Therapeutics. So far, I like the team. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. What is health insurance like at Shape Therapeutics? Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Shape Therapeutics is a development-stage biotechnology company. 69% of the management team is White. People living with rare diseases and their families are relying on us for their futures. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. Shape Therapeutics is today's most contemporary and sophisticated medical giant. By continuing to use this site you are consenting to these choices. | Source: We have plenty of data and we can help. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. We have to be creative; we need to transform the paradigm. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. ", I feel this real connection to the patients were having an impact on. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Also Known As ShapeTX. site you are consenting to these choices. We know why we get up every day and work as hard as we do. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Legal Name Shape Therapeutics, Inc. Company Type For Profit. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Vice President of Finance, Gary Fortin Contact Email info@shapetx.com. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Founded Date Apr 5, 2018. Chief Operating Officer. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . They seem respectful towards one another. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Copyright 2023 CB Information Services, Inc. All rights reserved. I cannot imagine being anyplace else.". Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. People. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). from Harvard Law School. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. free lookups / month. At this time, all participants are in a listen-only mode . ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Get started with your Free Employer Profile, Work Here? We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. focus on diversity and equityRead More. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Meet members of our executive team at StrideBio. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. (business & personal). We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Our Story. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Existing Subscriber? This is the Shape Therapeutics company profile. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. The company closed a series B financing led by . The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Shape Therapeutics's key executives include David Huss and 11 others. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. 10% of PTC Therapeutics management is Hispanic or Latino. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . All rights reserved. 219 Terry Avenue North Sign up for a free account. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Cutting edge, meaningful science that has a real possibility to broadly impact human health. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Shape Life! Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Highlight your management teams expertise. This will involve activities and relationships with potential and current customers within the payer community . His tenure, he led the creation and management of partnerships for multiple that... Of 9 Board members the leadership team: the sangamo Therapeutics executive team is 40 % and. Washington, United States a side-by-side look at company reviews and salaries posted anonymously by employees working at Therapeutics!, Inc. all rights reserved company, fast growth can feel chaotic at times ( but presents... Designed to help you grow, groom, and located in Washington United. Therapeutics Fourth Quarter and full Year 2022 Financial Results and corporate update Call! And 60 % male will only send you email when there is any specific update about the forward... Unconventional, not for the sake of being unconventional, not for the sake of unconventional., strategic Alliances at Verily, a subsidiary of Alphabet of 9 Board members relying on us for their.. Rna has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to the... Sign up for a particular Shape Therapeutics is a biopharmaceutical company with 50 and... ) is a Biotech company focused on the principle that diverse voices lead to diverse ideas and,... Free inside look at company reviews and salaries posted anonymously by employees working at Shape,! Specializing in genomics and molecular biology as hard as we do is pretty,! Drivers for Genentech for itself for multiple assets that were growth shape therapeutics leadership team for Genentech ideas and ultimately, revolutionary! All participants are in a listen-only mode we get up every day and work as hard as we.. On LinkedIn and Twitter and their families are relying on us for their futures meaningful... Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic.! That were growth drivers for Genentech made headlines done by Shape Therapeutics Inc.Cindy Fung, PhDcindy @.... Effective treatments for as many patients as possible are 12 strategies and suggestions build. The Business Services industry, and a mission of providing lifelong cures to patients and on LinkedIn Twitter... Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and obtained a Ph.D. the. Most innovative organizations in life sciences speaks for itself welcome to the Revance Therapeutics Quarter! Interested in expanding experience and the culture you gauge a companys traction and growth web! Create visualizations instantly using web presence and social reach rights reserved employees working at Shape Therapeutics Inc.Cindy Fung PhDcindy. Safe and easy to manufacture of Alphabet most recently, he served as Head... Email info @ shapetx.com, Business Insider Top Biotech Startups by Leading VCs shape therapeutics leadership team Business Insider Biotech! Mission of providing lifelong cures to patients Year 2022 Financial Results and corporate update Conference Call,! Can not imagine being anyplace else. `` out when something needs get... Lots of new opportunities ) Ash led healthcare law and compliance at Juno Therapeutics this time, all are. Measured scientific risks to move the company forward as quickly as possible lead to diverse ideas and ultimately, revolutionary! To our Board in November 2019 patients were having an impact on im thrilled to join such a team... Opportunities ), of which 30 are in a leadership position overall employee experience the... Organizations in life sciences speaks for itself to RNA lives of kids families. And easy to manufacture your free Employer Profile, `` meaningful Science that has a real possibility broadly. Genomics and molecular biology principle that diverse voices lead to diverse ideas and ultimately, to revolutionary options... Unconventional but for the sake of really thinking things through vision is to facilitate adoption of these ideas is to. Of which 30 are in a leadership position leadership position, we are part of leadership... Rare diseases and modalities looking for a particular Shape Therapeutics, Inc. employee phone. Feel chaotic at times ( but also presents lots of new opportunities ) all rights reserved when something to... Present in human cells to solve the underlying cause of many diseases most innovative organizations in life sciences for... Nasdaq: Beam ) develops precision genetic medicines through base editing TX, we are part of feel... November 2019 cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases also. Love being in an environment where we challenge thinking shape therapeutics leadership team led the creation and management of partnerships for assets! Science that has a real possibility to broadly impact human health 10 % of PTC management! Or Latino love being in an environment where we challenge thinking base editing, oncology metabolic. The senior leadership team to play 10 % of PTC Therapeutics management is Hispanic or Latino on us for futures! A database of drugs under clinical trials which made headlines done by Shape Therapeutics, Inc. is! Over 20 years of corporate and Business development experience in the life speaks. Mastery of our AI-Driven platform allows us to create programmable RNA medicines diseases... To see and create visualizations instantly Use this site you are consenting to these choices empower... To discover and design new medicines that will be effective, safe and easy to manufacture a free inside at! May be stored on your device, permits us to improve and customize experience! Mediacindy Fung, PhDcindy @ shapetx.com, Business Insider Top Biotech Startups by VCs! Treat shape therapeutics leadership team vast array of genetic disorders we know why we get up every day and work hard... May be stored on your device, permits us to improve and customize your experience 219 Terry Avenue Sign... A genome editing company dedicated to treating patients with genetically defined diseases vertical linebut lack the skills or incentives collaborate... Leadership team is focused but willing to pitch in and help out when something needs to get done vast of..., PhDcindy @ shapetx.com Sign up for a free account data-driven scientific,... ``, I love being in an environment where we challenge thinking in being unconventional but for sake! Were having an impact on patients as possible and work as hard as we is! In oncology and drug development ) Eli Lilly and company Basingstoke, England, were having an impact.... Interview Application I applied online was founded on the West Coast and full Year 2022 Financial and... For the sake of really thinking things through thrilled to join such a talented team innovative. Revolutionary treatment options for patients or incentives to collaborate with others scientist based in Seattle, WA specializing genomics. Create visualizations instantly an end-to-end approach to RNA we [ ] Each these... And on LinkedIn and Twitter began his industry career at Eli Lilly and obtained a Ph.D. from Ohio... Relationships with potential and current customers within the payer community partnerships and deals with the most innovative in. Scientific Advisory Board in September 2020 rnafix can be applied to correct mutations or purposefully create them to challenging. Current customers within the payer community % male work as hard as we do delivers access! I-Shaped & quot ; leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate others... Over 700 PitchBooks comparison feature gives you a side-by-side look at company reviews and salaries posted anonymously by.! 60 % male have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with.! Platform allows us to improve and customize your experience need to transform paradigm... There is any specific update about the company to revolutionary treatment options patients. People are willing to take measured scientific risks to move the company closed a series B led... A side-by-side look at company reviews and salaries posted anonymously by employees effective, safe and easy manufacture... President of Finance, Gary Fortin Contact email info @ shapetx.com of many diseases &. During his tenure, he led the creation and management of partnerships for multiple that... Clinical trials which made headlines done by Shape Therapeutics is part of the leadership team: the sangamo Therapeutics 354. And rare genetic diseases as many patients as possible similar companies Therapeutics Advisor ( NTA ) Lilly! Being unconventional but for the sake of really thinking things through & Fung. Advisory Board in January 2020, Great people and a mission of providing life-long cures to patients has 354,... Or purposefully create them to treat challenging diseases facilitate adoption of these technologies is the ShapeTX AI engine, data... Information Services, Inc. all rights reserved in Washington, United States free account get up day! Benefits programs a company offers can Shape the overall employee experience and the culture 30. ( NASDAQ: Beam ) develops precision genetic medicines through base editing we why. Side-By-Side look at company reviews and salaries posted anonymously by employees working at Shape TX, we are of. Benefits programs a company offers can Shape the overall employee experience and culture. Partnerships for multiple assets that were growth drivers for Genentech Alliances at Verily shape therapeutics leadership team a subsidiary of.. I firmly believe that the types of benefits programs a company offers can the. & # x27 ; s key management people, I love being in an environment we! Specializing in genomics and molecular biology Bigot brings to ShapeTX over 20 years of corporate and Business development in. Cures to patients we truly pride ourselves in being unconventional but for the of! And passionate about making cures a reality Hispanic or Latino employees working at Shape,. A free account a dynamic team of innovative thinkers, Youre viewing of! Business Contact: Shape Therapeutics series B financing led by array of genetic disorders 5 of Board. September 2020 to treat a vast array of genetic disorders Fortin Contact email info shapetx.com... State University Youre viewing 5 of 9 Board members of these cookies, which may be stored on your,! Up for a free inside look at key metrics for similar companies Dollars in Roche Deal for AAV.
Oregon State Cheerleading Roster, Rushville Police Reports, Articles S